Autonomic changes in young smokers: acute effects of inspiratory exercise

Carregando...
Imagem de Miniatura
Citações na Scopus
7
Tipo de produção
article
Data de publicação
2013
Editora
SPRINGER HEIDELBERG
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
RODRIGUES, Fernando
ARAUJO, Amanda Aparecida
FERREIRA, Janaina
SILVA, Michelle Cristina de Barros
NASCIMENTO, Ademir Manoel
LIRA, Fabio Santos
ANGELIS, Katia De
RODRIGUES, Bruno
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
CLINICAL AUTONOMIC RESEARCH, v.23, n.4, p.201-207, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
One of the most important consequences of smoking is the development of cardiovascular diseases. However, little is known about the early consequences of smoking and the acute effects of a single inspiratory muscle exercise session (IME). We evaluated the acute effects of an IME on cardiac parameters of young smokers. Twelve nonsmokers (C) and fifteen smokers [S; 2.08 (1.0-3.2) pack-years] underwent an acute IME. We evaluated blood pressure (BP) and lactate, and we recorded RR interval for posterior analysis of heart rate variability (HRV), before and after IME. At baseline, systolic BP and HRV parameters in time and frequency domains were changed in S group in comparison with the C. Following IME, S group reduced systolic BP (-8 %), low frequency band (LF) (-21.4 %), LF/high frequency (HF) (-57 %), as well as increased RR variance (+105 %) and HF band. Our findings indicate that a single session of inspiratory muscle exercise was able to both reduce systolic BP and improve parasympathetic and sympathetic modulations in young smokers. The results of the current study highlight the importance of furthering research on this area to better elucidate the acute and chronic effects of inspiratory muscle training on early cardiovascular and pulmonary changes of cigarette smoking.
Palavras-chave
Smoking, Inspiratory muscle exercise, Autonomic function
Referências
  1. Adamopoulos D, 2008, CLIN EXP PHARMACOL P, V35, P458, DOI 10.1111/j.1440-1681.2008.04896.x
  2. Bernardi L, 2001, AUTON NEUROSCI-BASIC, V90, P47, DOI 10.1016/S1566-0702(01)00267-3
  3. Carlsson S, 2004, DIABETOLOGIA, V47, P1953, DOI 10.1007/s00125-004-1554-9
  4. Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2
  5. Esler M, 2006, HYPERTENSION, V48, P787, DOI 10.1161/01.HYP.0000242642.42177.49
  6. Ferreira JB, 2013, INT J CARDIOL, V166, P61, DOI 10.1016/j.ijcard.2011.09.069
  7. Foy CG, 2005, DIABETES CARE, V28, P2501, DOI 10.2337/diacare.28.10.2501
  8. Francica JV, 2013, EUR J PREV CARDIOL, V20, P480, DOI 10.1177/2047487312452502
  9. Goldenberg I, 2006, J CARDIOVASC ELECTR, V17, P931, DOI 10.1111/j.1540-8167.2006.00526.x
  10. Goso Y, 2001, CIRCULATION, V104, P418, DOI 10.1161/hc2901.093111
  11. Gosselink R, 2011, EUR RESPIR J, V37, P416, DOI 10.1183/09031936.00031810
  12. GRASSI G, 1994, CIRCULATION, V90, P248
  13. Grossman E, 2001, J HUM HYPERTENS, V15, P263, DOI 10.1038/sj.jhh.1001147
  14. Hanna ST, 2006, J CARDIOVASC PHARM, V47, P348
  15. Katz A, 2006, J CARDIOVASC ELECTR, V17, P937, DOI 10.1111/j.1540-8167.2006.00573.x
  16. MALLIANI A, 1991, CIRCULATION, V84, P482
  17. Masuo K, 1997, AM J HYPERTENS, V10, P77, DOI 10.1016/S0895-7061(96)00303-2
  18. Mello PR, 2012, J CARDIOPULM REHABIL, V32, P255, DOI 10.1097/HCR.0b013e31825828da
  19. Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805
  20. Minami J, 1999, HYPERTENSION, V33, P586
  21. Mourya M, 2009, J ALTERN COMPLEM MED, V15, P711, DOI 10.1089/acm.2008.0609
  22. Narkiewicz K, 1998, CIRCULATION, V98, P528
  23. SOMERS VK, 1988, HYPERTENSION, V11, P608
  24. Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654
  25. World Health Organization, 2011, WHO REP GLOB TOB EP
  26. ZHU BQ, 1995, AM HEART J, V130, P1270, DOI 10.1016/0002-8703(95)90154-X